// App-Quantinova.ai

613 : Assessment of non invasive markers of fibrosis against collagen quantitation and NASH‐CRN scoring in liver biopsies of NAFLD patients

Researchers

Presenter

  • Roberta Forlano

Principal Investigators

  • Pinelopi Manousou

  • Benjamin Mullish

  • Adeola Olaoke

  • Mohamed Z. Khelifa

  • Nikos Giannakeas

  • Alexandros Tzallas

  • Markos G. Tsipouras

  • Michael Yee

  • Simon D. Taylor-Robinson

  • Josephine Lloyd

  • Robert D. Goldin

  • Mark R. Thursz

  • Shahid A. Khan

Medical Centers

  • Liver Unit/ Division of Digestive Diseases, Imperial College London, Paddington, London, United Kingdom

  • Department of Computer Engineering, Technological Educational Institute, Epirus, Greece

  • Department of Computer Engineering, Greece, Greece

  • Department of Histopathology, Imperial College London, London, United Kingdom

  • Department of Histopathology, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Nonalcoholic steatohepatitis

Biomarkers

  • Aspartate transaminase-platelet ratio index

  • Fibrosis-4

Drug/Treatment

  • Desogestrel/ethinyl estradiol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved